Amylyx Pharmaceuticals Inc (AMLX) Government Trades - Latest Congressional Stock Transactions
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.
top performing (AMLX) trades
Chris Jacobs
House (R-NY)
-65.80%
Recent Amylyx Pharmaceuticals (AMLX) Trades by Congress Members
See the most up-to-date Amylyx Pharmaceuticals trades disclosed by US lawmakers, including purchase and sale amounts, transaction dates, and reporting details. View the most recent Amylyx Pharmaceuticals trades made by congress members.
Chris JacobsHouse (R-NY) | $1K - $15K | stock | Purchase | Nov 16, 2022 | Oct 12, 2022 | House |
